← Leaderboards
Franklin O. Smith
Indiana Univ-Purdue Univ At Indianapolis
$277,433
Attributed
$277,433
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $135.3K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
FDA$240,055 · 1
NIH$37,378 · 6
By mechanism
R01$240,055 · 1
M01$37,378 · 6
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Mary C Dinauer$7,798,092
- David Collin Williams$5,510,592
- Edward F Srour$12,800,260
- Kenneth G Cornetta$19,602,964
- Hal E. Broxmeyer$36,408,829
Others in their field
Top investigators on “Oxymetholone”
- Markus Grompe · Oregon Health And Science University$2,969,288
- Amos B Smith · University Of Pennsylvania$279,739
- Victoria Jaque · University Of Southern California$0
- David Alastair Flockhart · Georgetown University$0
Research focus
OxymetholonePancytopeniaHandOxandroloneAndrogensBone MarrowBehavior AssessmentAdverse EffectsInstitutionMoodsBone And BonesComplete Blood CountComputer Retrieval Of Information On Scientific Projects DatabaseCountDoseEnrollmentFanconi&AposAggressive BehaviorFundingBloodLiverMonitorGrantPharmaceutical Preparations
Grant awards (15)
CLINICAL TRIAL: OXANDROLONE FOR TREATMENT OF BONE MARROW APLASIA$6,242
M01 · FY2008 · RR · contact PI
OXANDROLONE FOR THE TREATMENT OF MARROW APLASIA IN FANC*$121,880
R01 · FY2007 · FD · contact PI
OXANDROLONE FOR TREATMENT OF BONE MARROW APLASIA$11,700
M01 · FY2007 · RR · contact PI
OXANDROLONE FOR THE TREATMENT OF MARROW APLASIA IN FANC*$118,175
R01 · FY2006 · FD · contact PI
OXANDROLONE FOR TREATMENT OF BONE MARROW APLASIA$17,131
M01 · FY2006 · RR · contact PI
OXANDROLONE FOR TREATMENT OF BONE MARROW APLASIA$1,844
M01 · FY2005 · RR
FANCONI ANEMIA REINFUSION STUDY$461
M01 · FY2005 · RR
OXANDROLONE FOR THE TREATMENT OF MARROW APLASIA IN FANC*$0
R01 · FY2005 · FD
TRANSDUCTION OF BLOOD CELLS W/ GP91PHOX IN GRANULOMATOUS$0
M01 · FY2002 · RR
TRANSDUCTION OF BLOOD CELLS W/ GP91PHOX IN GRANULOMATOUS$0
M01 · FY2001 · RR
TRANSDUCTION OF BLOOD CELLS W/ GP91PHOX IN GRANULOMATOUS$0
M01 · FY2000 · RR
TRANSDUCTION OF BLOOD CELLS W/ GP91PHOX IN GRANULOMATOUS$0
M01 · FY2000 · RR
TRANSDUCTION OF BLOOD CELLS W/ GP91PHOX IN GRANULOMATOUS$0
M01 · FY2000 · RR
TRANSDUCTION OF BLOOD CELLS W/ GP91PHOX IN GRANULOMATOUS$0
M01 · FY2000 · RR
TRANSDUCTION OF BLOOD CELLS W/ GP91PHOX IN GRANULOMATOUS$0
M01 · FY2000 · RR